250.000 EUR investment for Mediq, radiotherapy startup for identifying tumors

  • October 25, 2021
  • start-up.ro
  • 2 min read

Synaptiq, a Romanian startup from Cluj-Napoca that increases the performance of healthcare services by developing AI-based solutions for delineating tumors and organs at risk, closes a €250,000 funding round with the participation of investment fund GapMinder VC through business accelerator Techcelerator, Cleverage VC and angel investors – entrepreneurs Daniel and Ioan Istrate.

The startup is working on the development of Mediq platform, which reduces the analysis time of medical images in radiotherapy cancer treatment procedures.

The startup stood out in the Advancing AI SEE program developed by Techcelerator in partnership with Google for Startups dedicated to artificial intelligence-based solutions, with its high-tech product and the major need it addresses.

The Synaptiq team was declared the winner of the “Investors Days” competition, an event run with notable participation from reputable local and international investment funds and investors. Previously, the Synaptiq team attended the accelerator program sessions and was assisted in the investment readiness process by Techcelerator’s team of experts.

With the funding received, Synaptiq will continue the R&D work to develop the final version of the Mediq product, allocate resources to the clinical trial needed to obtain European accreditation, and invest in the commercialization of the software. In addition, these resources have made it possible to expand the Synaptiq team to ten expert members with solid experience in specialized institutes from Germany and the Netherlands.

Read more on start-up.ro.